ADAC makes artifact correction gains

Article

ADAC Medical Systems, thenewly created equipment division of ADAC Laboratories, will displayVantage, its simultaneous transmission-emission attenuation correctiontechnique for the Vertex adjustable dual-head gamma camera (SCAN6/1/94). The technique is

ADAC Medical Systems, thenewly created equipment division of ADAC Laboratories, will displayVantage, its simultaneous transmission-emission attenuation correctiontechnique for the Vertex adjustable dual-head gamma camera (SCAN6/1/94). The technique is useful in eliminating artifacts createdduring nuclear cardiology procedures. ADAC has submitted a 510(k)application with the Food and Drug Administration for the techniqueand expects to have marketing clearance by December.

ADAC, of Milpitas, CA, will emphasize the throughput advantagesof using Vantage with the gamma camera detectors in the 90ºconfiguration. This offers higher throughput compared to similartechniques used on triple-head cameras, according to Ian Farmer,vice president of nuclear medicine marketing. Picker, the onlyvendor with a simultaneous attenuation correction technique onthe market, uses the technology on its triple-head Prism 3000camera (SCAN 6/1/94).

ADAC will also display 511-KeV collimators for fluorodeoxyglucose(FDG) imaging with Vertex. ADAC expects the technique to showutility in oncology imaging, Farmer said.

On the radiology information systems side, ADAC HealthcareInformation Systems will highlight its QuadRIS product, introducedearlier this year. ADAC will also show its progress in developingan information system for mammography facilities.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.